ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 040047957. A total of 4 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,171,000 | +724.6% | 12,600 | +530.0% | 0.00% | – |
| Q3 2021 | $142,000 | +4.4% | 2,000 | 0.0% | 0.00% | – |
| Q2 2021 | $136,000 | -87.0% | 2,000 | +1224.5% | 0.00% | -100.0% |
| Q1 2021 | $1,047,000 | +18.6% | 151 | +31.3% | 0.00% | +100.0% |
| Q4 2020 | $883,000 | +238.3% | 115 | +228.6% | 0.00% | – |
| Q3 2020 | $261,000 | -51.2% | 35 | -58.8% | 0.00% | -100.0% |
| Q2 2020 | $535,000 | +435.0% | 85 | +254.2% | 0.00% | – |
| Q1 2020 | $100,000 | -83.7% | 24 | -82.2% | 0.00% | -100.0% |
| Q4 2019 | $613,000 | +5.5% | 135 | +6.3% | 0.00% | -50.0% |
| Q3 2019 | $581,000 | +353.9% | 127 | +477.3% | 0.00% | – |
| Q2 2019 | $128,000 | +30.6% | 22 | 0.0% | 0.00% | – |
| Q1 2019 | $98,000 | -84.0% | 22 | -86.0% | 0.00% | -100.0% |
| Q4 2018 | $611,000 | -24.1% | 157 | -10.3% | 0.00% | -33.3% |
| Q3 2018 | $805,000 | -14.5% | 175 | -19.0% | 0.00% | -25.0% |
| Q2 2018 | $941,000 | +1820.4% | 216 | +12.5% | 0.00% | +100.0% |
| Q1 2018 | $49,000 | +880.0% | 192 | +106.5% | 0.00% | – |
| Q4 2017 | $5,000 | -70.6% | 93 | -38.0% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | -48.5% | 150 | -37.8% | 0.00% | 0.0% |
| Q2 2017 | $33,000 | – | 241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 71,000 | $4,469,000 | 0.02% |
| SIMPLEX TRADING, LLC | 85 | $535,000 | 0.00% |
| JPMORGAN CHASE & CO | 35,000 | $2,203,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |